| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |